Education Hub
Your central resource for evidence-based content in metabolic, cardiovascular, and renal medicine.
Core Topics
Landmark Trials
Educational summaries and commentary on pivotal clinical trials...
Coming Soon - New landmark trial videos will be added here shortly.
Number of videos found or no matching video
Heading 1
I'm a paragraph. Click here to add your own text and edit me. It's easy.
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Heading 1
I'm a paragraph. Click here to add your own text and edit me. It's easy.
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Heading 1
I'm a paragraph. Click here to add your own text and edit me. It's easy.
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Heading 1
I'm a paragraph. Click here to add your own text and edit me. It's easy.
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Heading 1
I'm a paragraph. Click here to add your own text and edit me. It's easy.
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Heading 1
I'm a paragraph. Click here to add your own text and edit me. It's easy.
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Landmark Trials
Contemporary approaches to diabetes management, complications, and therapeutic advances.
Diabetes
Contemporary approaches to diabetes management, complications, and therapeutic advances.
CGM for Type 2 Diabetes... the NICE guidance
11:25
In this GoggleDocs video Dr Amar and Dr Amrit discuss how Continuous Glucose Monitoring (CGM) could revolutionise the insulin management in Type 2 Diabetes.
Glucose Monitoring in Type 1 Diabetes... the NICE guidance
11:03
In this @GoggleDocs video Dr Patrick and Dr Amar summarise the NICE Guidance on Glucose Monitoring in Type 1 Diabetes.
Diabetes and Obesity - ADA 2023 Preview
14:15
In this video @GoggleDocs will preview the annual American Diabetes Association's Scientific Sessions conference which takes place in San Diego.
Type 1 Diabetes: The Power of Early Detection
12:20
This video (including its concept, creation and content) has solely been developed and produced by Dr Patrick Holmes and Dr Amrit Lamba.
Disrupting Type 2 Diabetes: Mounjaro's UK Launch
14:33
Patrick and Amrit discuss the launch of Mounjaro, the latest blockbuster medication in the management of type 2 diabetes.
ADA 2025: The Big 4 (Plus One) – Key Trials That Could Reshape Diabetes
8:51
Five high-impact trials from #ADA2025 – broken down fast by Drs Amrit Lamba, Amar Puttanna, and Patrick Holmes.
Obesity
Weight management, metabolic health, and the evolving treatment landscape for obesity.
Weight loss management... NEW OPTIONS
14:29
In this video our GoggleDocs team look at the recently announced NICE technical appraisal document for the use of Semaglutide in Overweight and Obesity.
MOUNJARO: Mastering Weight Loss Maintenance | SURMOUNT-4 at EASD
5:42
Join @goggledocs, as we discuss the latest science investigating the durability of weight loss when using Mounjaro.
CagriSema: REDEFINE 1 & 2 Results – ADA 2025 – will two be better than one?
1:24
Two phase 3 trials, two populations, one dual-incretin therapy. Dr Patrick Holmes breaks down REDEFINE 1.
Obesity and Cardiovascular Disease
33:16
In this @GoggleDocs podcast, we take a deep dive on Obesity and Overweight - looking at international trends, the risk of cardiovascular disease and the different treatment modalities.
The Human Costs of Obesity
10:30
In this @GoggleDocs podcast we discuss the far-reaching consequences of overweight and obesity, including the role of social deprivation and health inequalities.
Can #orforglipron an oral #glp1 maintain #weightloss ?: The ATTAIN MAINT...
2:18
This is a video about ATTAIN MAINTAIN Trial-2 1 00:00 ATTAIN MAINTAIN Trial-2 1
Cardiovascular and Kidney Conditions
Heart failure, chronic kidney disease, atherosclerotic cardiovascular disease, lipid disorders, and other conditions in metabolic medicine.
Weight, Risk & Heart Health | Insights from ESC 2023
17:17
We pick our top three Heart health announcements from the ESC Annual Congress in Amsterdam (August 2023); covering the latest on Semaglutide in heart failure.
The Heart Failure breakthrough of 2024?
10:57
@GoggleDocs summarise the breaking news in Heart Failure management with Finerenone's (Kerendia) latest scientific data.
Semaglutide Saving Lives in Kidney Disease
12:00
In this video @GoggleDocs review the latest evidence for using Semaglutide in the management of people with Chronic Kidney Disease and Type 2 Diabetes.
Finerenone... adding life to years in Kidney Disease
4:59
@GoggleDocs give a summary of the latest NICE recommendations for Finerenone and the practical aspects of its use.
ESC 2022 - latest cardiology research reviewed
20:48
The GoggleDocs team review the recent European Society of Cardiology (ESC) Congress 2022, Barcelona, and highlight their key sessions.
Breakthroughs in Kidney Disease & Heart Failure
10:53
@GoggleDocs summarises evidence from the EMPA-KIDNEY and DELIVER studies, and how they impact clinical practice and people living with CKD.